The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20051759
Johnson et al.

Figure S1 Characteristics of TNF-α-induced CAM expression in cultured HDLECs: dose response and effects on other adhesion molecules.

Figure S2 Characteristics of TNF-α-induced CAM expression in cultured HDLECs: reversibility and effects on cell proliferation.

Figure S3 TNF-α-induced expression of ICAM-1, VCAM-1, and proinflammatory chemokines in primary MDLECs.

Figure S4 Close association of MHC class II+ leukocytes with ICAM-1+ lymphatic vessels.

Figure S5 Phenotype of human MDDCs.

Figure S6 Characteristics of HDLEC monolayers used for in vitro DC transmigration assays.

Figure S7 Dose-dependent reduction of DC transmigration across TNF-α-treated HDLECs by ICAM-1-neutralizing mAb 15.2.

Figure S8 TNF-α-activated HDLECs support MDDC transmigration in both directions.

Tables S1 and S2 (PDF)





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS